24-Hour ambulatory blood pressure in the ACCOMPLISH trial

New England Journal of Medicine

Volumn 363, Issue 1, 2010, Pages 98-

  Jamerson, Kenneth A ^a   Bakris, George L ^b   Weber, Michael A ^c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; AMLODIPINE PLUS BENAZEPRIL; BENAZEPRIL PLUS HYDROCHLOROTHIAZIDE; CHLORTALIDONE; HYDROCHLOROTHIAZIDE;

BLOOD PRESSURE MONITORING; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; HUMAN; HYPERTENSION; LETTER; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 77954191608     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1001410     Document Type: Letter

References (3)

1. Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008;359:2417-28.
2. Jamerson KA, Weber MA. Benazepril plus amlodipine or hydrochlorothiazide for hypertension. N Engl J Med 2009;360: 1147-50.
3. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 2008;336:1121-3.